<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01567644</url>
  </required_header>
  <id_info>
    <org_study_id>ESMR-NRW-DE</org_study_id>
    <nct_id>NCT01567644</nct_id>
  </id_info>
  <brief_title>Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris</brief_title>
  <official_title>Clinical Trial Evaluating the Treatment of Patients With Refractory Chronic Angina Pectoris With Low Intensity Extracorporeal Shockwave Therapy Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medispec</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heart and Diabetes Center North-Rhine Westfalia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medispec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low intensity shockwaves have been proven in animal studies to induce local growth of new
      blood vessels from existing ones.

      The hypothesis of this study is that shockwave therapy could improve the symptoms of patients
      with refractory angina not amenable to revascularization with angioplasty or bypass surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Low intensity shockwaves (1/10 the ones used in Lithotripsy) are delivered to myocardial
      ischemic tissue. Shockwaves are created by a special generator and are focused using a
      shockwave applicator device. The treatment is guided by standard echocardiography equipment.
      The shockwaves are delivered in synchronization with Patient R-wave to avoid arrhythmias. The
      treatment is painless.

      At first, the patient undergoes stress- PET testing to identify the ischemic areas. Following
      that, the same area is localized by the ultra-sound device and the shockwaves are focused to
      the ischemic area. Several treatments are required for optimal results.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">September 2012</completion_date>
  <primary_completion_date type="Anticipated">April 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in AP-CCS</measure>
    <time_frame>6 Months</time_frame>
    <description>The AP CCS Stage at the 6 months post baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exercise tolerance time</measure>
    <time_frame>6 Months</time_frame>
    <description>The change in Total Exercise Time (Exercise Tolerance Test-ETT) from baseline to 6 months post baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in PET scan</measure>
    <time_frame>6 months</time_frame>
    <description>The change in perfusion in pharmacological induced stress PET scan (at rest and at stress) from baseline to 6 months post baseline.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Refractory Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>Active Shockwave Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group receive shockwave therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac Extracorporeal Shockwave Therapy generator (Cardiospec)</intervention_name>
    <description>Energy Density - 0.09 mJ/mm2</description>
    <arm_group_label>Active Shockwave Therapy</arm_group_label>
    <other_name>Cardiospec</other_name>
    <other_name>ESMR therapy</other_name>
    <other_name>Extracorporeal Shockwave Myocardial Revascularization</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with chronic stable angina pectoris.

          -  Documented myocardial segments with reversible ischemia

          -  AP CCS class of III-IV.

          -  Stable dosage of medication used to treat angina for at least 6 weeks prior to
             enrollment.

          -  Exercise tolerance time &lt; 10 min (modified Bruce)

          -  Two ETT tests results (within two weeks) averaging no more than 25% of their mean

          -  Documented epicardial coronary artery disease not amenable to angioplasty or CABG.

          -  Signed an IRB approved informed consent form.

          -  Life expectancy of &gt; 12 months.

        Exclusion Criteria:

          -  Intraventricular thrombus

          -  Malignancy in the area of treatment

          -  Severe COPD

          -  No smoking during the study procedure

          -  MI less &lt; 3 months prior to treatment

          -  Severe Valvular disease

          -  Child bearing potential
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lothar Faber, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart and Diabetes Center North-Rhine Westfalia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart and Diabetes Center North-Rhine Westfalia</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2010</study_first_submitted>
  <study_first_submitted_qc>March 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2012</study_first_posted>
  <last_update_submitted>April 1, 2012</last_update_submitted>
  <last_update_submitted_qc>April 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Extracorporeal Shockwave Therapy</keyword>
  <keyword>Myocardial Ischemia</keyword>
  <keyword>Refractory Angina</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

